ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Arthritis"

  • Abstract Number: 56 • 2019 ACR/ARP Annual Meeting

    Choline Metabolite Is Associated with Inflammation in Arthritis in the Elderly

    francesca cedola1, Roxana Coras 2, Elsa Sanchez-Lopez 3, Lourdes Mateo 4, Anders Pedersen 5, Anahy Brandy-Garcia 4, Águeda Prior-Español 4, Brin S rosenthal 6, Melania Martínez-Morillo 4 and Monica Guma 7, 1University of California San Diego, Rome, Italy, 2. Department of Medicine, School of Medicine. University of California, San Diego, 3Department of Pharmacology, University of California San Diego, La Jolla, San Diego, 4Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 5University of Gothenburg, Gothenburg, Sweden, 6University of California San Diego, san diego, 7Department of Medicine, School of Medicine. University of California San Diego, La Jolla, United States

    Background/Purpose: Elderly-onset RA (EORA) and polymyalgia rheumatica (PMR) are common rheumatic disease in the elderly and their pathogenesis are still not completely understood. Perturbations caused…
  • Abstract Number: 2139 • 2019 ACR/ARP Annual Meeting

    Rheumatic Immune-Related Adverse Events Associated with Treatment with Immune Checkpoint Inhibitors: A Multicenter Study of 38 Cases

    Sebastian Rodriguez-Garcia1, David Lobo 2, Fabiola Ojeda 3, Raul Castellanos-Moreira 4, Ana Laiz 2, Roberto Gumucio 4, Cesar Diaz-Torné 2, Virginia Ruiz-Esquide 5, Milena Millan 2, Ivan Castellvi 6, Patricia Moya Alvarado 7, Berta Magallares 2, Carolina Perez 3, Hector Corominas 8 and Jose Gomez-Puerta 9, 1Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Spain, 2Rheumatology Department. Hospital Sant Pau, Barcelona, Catalonia, Spain, 3Rheumatology Department. Hospital del Mar, Barcelona, Catalonia, Spain, 4Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain, 5Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, 6Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 7Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain, 8Rheumatology Department, Hospital Sant Pau, Barcelona, Catalonia, Spain, 9Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Spain

    Background/Purpose: Immune checkpoint inhibitors (ICI) against CTLA-4 or PD- 1/PD-L1 and more recently TIM3,  have demonstrated efficacy in improving the survival of patients with diverse…
  • Abstract Number: 99 • 2019 ACR/ARP Annual Meeting

    Mass Cytometry Immunophenotyping of Synovial Fluid from Checkpoint Inhibitor Related Arthritis

    Runci Wang1, Karmela Kim Chan 2, Amy Cunningham-Bussel 3, Laura Donlin 4, Gregory Vitone 2, Aidan Tirpack 2, Caroline Benson 2, Gregory Keras 3, Anna Helena Jonsson 5, Michael Brenner 6, Anne Bass 7 and Deepak Rao 1, 1Brigham and women's hospital, Boston, MA, 2Hospital For Special Surgery, New York, 3Brigham and women's hospital, Boston, 4Hospital For Special Surgery, New York, NY, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 6Brigham and Women’s Hospital:, Boston, 7Hospital for Special Surgery/Weill Cornell Medicine, New York, NY

    Background/Purpose: Anti-PD-1/PD-L1 checkpoint inhibitor therapies have produced remarkable results in stimulating immune responses against tumors. Checkpoint inhibitor therapy can also trigger a variety of autoimmune…
  • Abstract Number: 2157 • 2019 ACR/ARP Annual Meeting

    Checkpoint Inhibitor-Associated Arthritis: Phenotype, Steroid Dose, Serology and Survival

    Karmela Kim Chan 1, Aidan Tirpack 1, Caroline Benson 1, Gregory Vitone 1, Jackie Finik 2, Vivian Bykerk 3, Susan Goodman 4, Laura Donlin 5, Deepak Rao 6 and Anne Bass4, 1Hospital For Special Surgery, New York, 2Hospital for Special Surgery, New York, NY, New York, NY, 3Hospital for Special Surgery, New York City, NY, 4Hospital For Special Surgery/Weill Cornell Medicine, New York, NY, 5Hospital For Special Surgery, New York, NY, 6Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Previous studies suggest that steroid dose1and rheumatoid factor positivity2 impact cancer survival in checkpoint inhibitor (CI)-treated patients (with CI-associated hypophysitis, and in all-comers with non-small…
  • Abstract Number: 114 • 2019 ACR/ARP Annual Meeting

    Persistent Synovial Resident Memory T Cells Mediate Arthritis Flares

    Margaret Chang1, Anaïs Levescot 2, Rachel Blaustein 2, Nathan Nelson-Maney 2, Allyn Morris 2, Robert Fuhlbrigge 3 and Peter Nigrovic 4, 1Division of Immunology, Boston Children's Hospital, Boston, 2Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, 3Department of Rheumatology, Children’s Hospital Colorado, Denver, CO, 4Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA ; Department of Medicine, Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA., Boston

    Background/Purpose: Resident memory T cells (TRM) are site-specific memory T cells that take up long-term residence in peripheral tissues and aid in pathogen defense. However,…
  • Abstract Number: 2324 • 2019 ACR/ARP Annual Meeting

    Metabolic Syndrome and Early Arthritis: Frequency, Association with Antibodies Profile and Disease Activity

    Francisco Guiñazú1, Carla Gobbi 2, Paula Alba 1, Carla Maldini 3, Carla Alonso 1, Alejandro Albiero 1, Eduardo Albiero 1, Viviana Neme 4, Marcela Demarchi 4 and Marcelo Yorio 3, 1UNIDAD DE REUMATOLOGÍA, CÁTEDRA DE SEMIOLOGÍA, HOSPITAL CÓRDOBA, FACULTAD DE CIENCIAS MÉDICAS, UNIVERSIDAD NACIONAL DE CÓRDOBA, ARGENTINA, Cordoba, Cordoba, Argentina, 2CÁTEDRA DE CLÍNICA MÉDICA I, HOSPITAL CÓRDOBA, FACULTAD DE CIENCIAS MÉDICAS, UNIVERSIDAD NACIONAL DE CÓRDOBA, ARGENTINA, Cordoba, Cordoba, Argentina, 3CÁTEDRA DE SEMIOLOGÍA, HOSPITAL CÓRDOBA, FACULTAD DE CIENCIAS MÉDICAS, UNIVERSIDAD NACIONAL DE CÓRDOBA, ARGENTINA, Cordoba, Cordoba, Argentina, 4SERVICIO DE BIOQUÍMICA. HOSPITAL CÓRDOBA, ARGENTINA, Cordoba, Cordoba, Argentina

    Background/Purpose: The Metabolic Syndrome (MetS) is an independent factor of cardiovascular morbidity and mortality and most studies show that its prevalence is higher in established…
  • Abstract Number: 979 • 2019 ACR/ARP Annual Meeting

    Platelet Derived Growth Factor Receptor Alpha (PDGFRα) Blockade Inhibits Arthritis in Mice

    Bhanupriya Madarampalli1, Paul Panipinto 1, Erica Chow 1, Kendahl Sugai 1, Fanqi Shi 1 and Erika Noss 1, 1University of Washington, Seattle, WA

    Background/Purpose: The interplay between infiltrating immune cells and activated joint stromal cells drives inflammation, cartilage destruction, and bone erosion in rheumatoid arthritis (RA). Among joint…
  • Abstract Number: 2722 • 2019 ACR/ARP Annual Meeting

    The down Syndrome Arthropathy Cohort in the New Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Clinical Characteristics, Treatment and Outcomes

    Jordan Jones1, Daniel J. Lovell 2, Chelsey Smith 3 and Mara Becker 4, 1Children's Mercy Kansas City, Kansas City, MO, 2Pediatric Rheumatology Collaborative Study Group (PRCSG), Cincinnati Children’s Hospital Medical Center, Cincinnati, 3Children's Mercy Kansas City, Kansas, MO, 4Duke Children's Hospital, Durham, NC

    Background/Purpose: Down syndrome arthropathy (DA) is under-recognized with a 19-month average delay in diagnosis (1). The majority present with polyarticular, rheumatoid factor (RF) and anti-nuclear…
  • Abstract Number: 984 • 2019 ACR/ARP Annual Meeting

    Important Role of CD11c+ Cells in Inflammatory Arthritis

    Antonia Puchner1, Elisabeth Simader 1, Victoria Saferding 2, Gerhard Kroenke 3, Rene Pfeifle 4, Daniel Aletaha 1, Josef Smolen 1 and Stephan Blueml 1, 1Medical University of Vienna, Vienna, Austria, 2Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria, 3Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Austria, 4University Hospital Erlangen, Erlangen, Germany

    Background/Purpose: Dendritic cells (DCs) are important antigen presenting cells (APCs) and therefore they play an important role in bridging the innate and the adaptive immune…
  • Abstract Number: 990 • 2019 ACR/ARP Annual Meeting

    Development of a Novel Anti TNF-Steroid Antibody Drug Conjugate That Shows Promising Efficacy at Doses That Avoid Steroid Side Effects in a Mouse Model of Rheumatoid Arthritis

    Wendy Waegell1, Christian Goess 2, Robert Stoffel 1, Michael McPherson 1, Adrian Hobson 1, Suzanne Mathieu 2, Lucy Phillips 1 and Shaughn Bryant 1, 1AbbVie, Worcester, 2Abbvie bioresearch Center, Worcester, MA

    Background/Purpose: TNF-inhibitors are a well established therapy for autoimmune diseases including rheumatoid arthritis, Crohn’s disease, psoriasis and ankylosing spondylitis but they have limited efficacy in…
  • Abstract Number: 998 • 2019 ACR/ARP Annual Meeting

    Stimulation of Splenic Neurovascular Bundle Protect Mice from Developing Collagen-induced Arthritis

    Thomas Simon1, Clara Panzolini 2, Julien Lavergne 2, Arun Srihar 3, Margriet Vervoordeldonk 3, nicolas Glaichenhaus 2 and Philippe Blancou 2, 1CNRS/IPMC, Valbonne, France, 2IPMC/CNRS, VALBONNE, France, 3Galvani Bioelectronics, Stevenage, United Kingdom

    Background/Purpose: Vagus nerve (VN) stimulation has shown the potential to improve the disease development in animal models of arthritis and in patients with RA. However,…
  • Abstract Number: 983 • 2018 ACR/ARHP Annual Meeting

    A MAPK Activated Kinase 2 Inhibitor Attenuates Inflammatory and Destructive Arthritis in Human Ex Vivo Models

    Tue Wenzel Kragstrup1,2, Anders Mellemkjær3, Morten Aagaard Nielsen4, Line Dam Heftdal2, Marie Iversen3, Peter Schafer5 and Bent Deleuran2, 1Randers Regional Hospital, Randers, Denmark, 2Department of Biomedicine, Aarhus University, Aarhus, Denmark, 3Aarhus University, Aarhus, Denmark, 4Of Biomedicine, Aarhus University, Aarhus, Denmark, 5Celgene Corporation, Summit, NJ

    Background/Purpose: Targeting intracellular pathways with oral small molecules is an attractive therapeutic approach for treating immune mediated inflammatory diseases. The mitogen-activated protein kinase (MAPK) pathway…
  • Abstract Number: 2027 • 2018 ACR/ARHP Annual Meeting

    Whole Exome Trio Sequencing Implicates DOCK2 in Juvenile Idiopathic Arthritis

    Laura A McIntosh1,2, Yoshinori Fukui3, Thomas A. Griffin4, Kenneth Kaufman1,2,5, Jarek Meller6,7, Sherry Thornton8, Halima Moncrieffe1,2 and Susan D Thompson1,2, 1Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Department of Pediatrics, University of Cincinnati, Cincinnati, OH, 3Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan, 4Levine Children’s Hospital at Carolinas Medical Center, Charlotte, NC, 5US Department of Veterans Affairs Medical Center, Cincinnati, OH, 6Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 7Department of Environmental Health, University of Cincinnati, Cincinnati, OH, 8Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease of childhood and has a strong genetic component to disease risk. Genome-wide association studies…
  • Abstract Number: 1007 • 2018 ACR/ARHP Annual Meeting

    Macrophage Mediators of Autoimmune Valvular Carditis and Fibrosis

    Lee Meier1, Mayra Gonzalez-Torres2, Jennifer L. Auger2, Aubyn Marath3 and Bryce A. Binstadt2, 1Department of Pediatrics and Center for Immunology, University of Minnesota, Minneapols, MN, 2Department of Pediatrics and Center for Immunology, University of Minnesota, Minneapolis, MN, 3CardioStart International, Tampa, FL

    Background/Purpose: K/B.g7 TCR transgenic mice spontaneously develop both autoimmune arthritis and valvular carditis. We utilize this model to define mediators of rheumatic disease-associated cardiovascular inflammation…
  • Abstract Number: 2048 • 2018 ACR/ARHP Annual Meeting

    In Vitro Proof-of-Concept of Pathobiology-Guided Therapy in Immune Mediated Inflammatory Arthritis

    Morten Aagaard Nielsen1, Bent Deleuran2,3 and Tue Wenzel Kragstrup2,3,4, 1Of Biomedicine, Aarhus University, Aarhus, Denmark, 2Department of Biomedicine, Aarhus University, Aarhus, Denmark, 3Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 4Randers Regional Hospital, Randers, Denmark

    Background/Purpose: Immune mediated inflammatory arthritis are very heterogeneous diseases including rheumatoid arthritis (RA), psoriatic arthritis (PsA) and spondyloarthritis (SpA). The available biological and targeted synthetic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology